NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

CDNA

Caredx Inc

Apr 23 • 04:00PM ET

17.84

Dollar change +0.07
Percentage change 0.37	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: NTRA ILMN FLGT GH EXAS TWST VRTX CRSP TXG QGEN

| Held by: ARKG VTI IWM XBI VXF VB IWN VBK IBB PBE

Scroll to Statements

Index	RUT	P/E	17.54	EPS (ttm)	1.02	Insider Own	7.06%	Shs Outstand	54.77M	Perf Week	-6.89%
Market Cap	988.80M	Forward P/E	-	EPS next Y	-0.02	Insider Trans	-0.97%	Shs Float	51.51M	Perf Month	-9.03%
Income	62.24M	PEG	-	EPS next Q	-0.21	Inst Own	100.61%	Short Float	10.79%	Perf Quarter	-23.07%
Sales	333.79M	P/S	2.96	EPS this Y	-148.39%	Inst Trans	3.48%	Short Ratio	6.99	Perf Half Y	-25.60%
Book/sh	6.91	P/B	2.58	EPS next Y	96.44%	ROA	12.57%	Short Interest	5.56M	Perf Year	114.68%
Cash/sh	4.70	P/C	3.79	EPS next 5Y	-19.23%	ROE	19.46%	52W Range	7.42 - 34.84	Perf YTD	-16.67%
Dividend Est.	-	P/FCF	31.33	EPS past 5Y	-	ROI	15.53%	52W High	-48.79%	Beta	2.20
Dividend TTM	-	Quick Ratio	3.72	Sales past 5Y	24.04%	Gross Margin	66.41%	52W Low	140.43%	ATR (14)	1.27
Dividend Ex-Date	-	Current Ratio	3.94	EPS Y/Y TTM	131.72%	Oper. Margin	-12.64%	RSI (14)	45.65	Volatility	5.47% 7.05%
Employees	650	Debt/Eq	0.07	Sales Y/Y TTM	19.07%	Profit Margin	18.65%	Recom	1.89	Target Price	31.06
Option/Short	Yes / Yes	LT Debt/Eq	0.06	EPS Q/Q	168.10%	Payout	0.00%	Rel Volume	0.83	Prev Close	17.77
Sales Surprise	2.94%	EPS Surprise	469.92%	Sales Q/Q	32.04%	Earnings	Apr 30 AMC	Avg Volume	794.98K	Price	17.84
SMA20	-1.01%	SMA50	-9.32%	SMA200	-23.58%	Trades		Volume	662,231	Change	0.37%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-15-25	Upgrade	Wells Fargo	Underweight → Equal Weight	$28 → $24
Aug-28-24	Initiated	Wells Fargo	Underweight	$28
Aug-19-24	Upgrade	BTIG Research	Neutral → Buy	$40
May-13-24	Downgrade	Raymond James	Outperform → Mkt Perform
May-01-24	Upgrade	Craig Hallum	Hold → Buy	$15
Nov-09-23	Upgrade	Stephens	Equal-Weight → Overweight	$10
Aug-15-23	Upgrade	Raymond James	Mkt Perform → Outperform	$12
May-11-23	Downgrade	BTIG Research	Buy → Neutral
Mar-07-23	Downgrade	Stephens	Overweight → Equal-Weight	$19 → $9
Mar-03-23	Downgrade	Raymond James	Strong Buy → Mkt Perform
Mar-03-23	Downgrade	Craig Hallum	Buy → Hold	$26 → $9
Apr-25-22	Initiated	Stephens	Overweight	$50
Jul-20-21	Resumed	BTIG Research	Buy	$115
Jun-03-21	Initiated	Goldman	Buy	$95
Feb-26-21	Downgrade	H.C. Wainwright	Buy → Neutral
Oct-30-20	Reiterated	H.C. Wainwright	Buy	$47 → $55
Oct-08-20	Reiterated	H.C. Wainwright	Buy	$45 → $47
Oct-02-20	Reiterated	H.C. Wainwright	Buy	$40 → $45
Aug-05-20	Reiterated	H.C. Wainwright	Buy	$37 → $40
Jun-26-20	Initiated	BTIG Research	Buy	$40

Show Previous Ratings

Apr-21-25 04:01PM	CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-08-25 07:05AM	CareDx to Report First Quarter 2025 Financial Results (Business Wire)
Apr-04-25 12:40PM	Elevance Health (ELV) Soars 5.4%: Is Further Upside Left in the Stock? (Zacks)
Mar-11-25 07:05AM	CareDx Launches Two Expanded Indications for AlloSure Testing Services (Business Wire)
Feb-27-25 02:20AM	CareDx Inc (CDNA) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
07:00PM	Loading…
Feb-26-25 07:00PM	CareDx (CDNA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
04:56PM	CareDx: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	CareDx Announces Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
Feb-25-25 10:39AM	CareDx Inc (CDNA) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
07:05AM	CareDx Announces District Court Reverses Jury Decision in Patent Infringement Case Overturning Prior $96 Million Verdict (Business Wire)
Feb-20-25 07:05AM	CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients (Business Wire) -5.34%
Feb-13-25 07:05AM	CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies (Business Wire)
Feb-11-25 07:05AM	CareDx to Report Fourth Quarter and Full Year 2024 Financial Results (Business Wire) -8.43%
03:22AM	CareDx (CDNA) Soars 11.2%: Is Further Upside Left in the Stock? (Zacks)
Feb-10-25 02:51PM	Trade Tracker: Amy Raskin trims Vertex, Natera & Kadant, buys CareDx and Impinj (CNBC TV) +11.16%
02:51PM	Loading…
02:51PM	Final Trades: NRG Energy, MP Materials, CareDx and Applovin (CNBC TV)
Feb-05-25 09:55AM	Does CareDx (CDNA) Have the Potential to Rally 42.25% as Wall Street Analysts Expect? (Zacks)
Jan-29-25 09:40AM	Is CareDx (CDNA) Outperforming Other Medical Stocks This Year? (Zacks)
Jan-28-25 08:19AM	CareDx (CDNA) Traded Down Due to Disappointing Quarterly Results (Insider Monkey)
Jan-24-25 08:35AM	Heres Why CareDx (CDNA) Traded Lower in Q4 (Insider Monkey)
Jan-15-25 03:50PM	Wells Fargo upgrades CareDx after a 30% pullback in stock (Investing.com)
Jan-14-25 03:43AM	Strength Seen in CareDx (CDNA): Can Its 6.1% Jump Turn into More Strength? (Zacks) -12.05%
Jan-13-25 07:00AM	CareDx Announces Preliminary Fourth Quarter and Full Year 2024 Results (Business Wire) +6.09%
Jan-06-25 09:35AM	Implied Volatility Surging for CareDx (CDNA) Stock Options (Zacks)
Dec-18-24 07:05AM	CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire) -7.86%
Dec-11-24 07:00AM	TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy (PR Newswire)
07:00AM	CareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy (Business Wire)
Dec-03-24 09:40AM	Has CareDx (CDNA) Outpaced Other Medical Stocks This Year? (Zacks)
Nov-29-24 10:46AM	Higher-Than-Anticipated Reimbursement Rates Lifted CareDx (CDNA) (Insider Monkey)
Nov-25-24 09:55AM	Wall Street Analysts Predict a 49.89% Upside in CareDx (CDNA): Here's What You Should Know (Zacks)
09:35AM	Loading…
Nov-15-24 09:35AM	After Plunging -11.97% in 4 Weeks, Here's Why the Trend Might Reverse for CareDx (CDNA) (Zacks)
Nov-14-24 09:40AM	Are Medical Stocks Lagging CareDx (CDNA) This Year? (Zacks) -5.40%
Nov-12-24 07:05AM	CareDx to Participate in Upcoming Investor Conferences (Business Wire)
Nov-07-24 09:04AM	Accelerated Testing Volume Lifted CareDx (CDNA) in Q3 (Insider Monkey)
Nov-05-24 01:03PM	Q3 2024 CareDx Inc Earnings Call (Thomson Reuters StreetEvents)
02:06AM	CareDx Inc (CDNA) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic ... (GuruFocus.com)
Nov-04-24 05:03PM	CareDx: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance (Business Wire)
Oct-23-24 07:00AM	CareDx and Dovetail Genomics Announce Strategic Partnership to Drive Next Wave of Innovation in Transplant Matching with Cutting-Edge Hi-C Technology (Business Wire)
Oct-21-24 07:00AM	CareDx Showcases Latest Advancements Across its HLA Typing Solutions at Annual American Society for Histocompatibility and Immunogenetics Meeting (Business Wire)
Oct-17-24 03:06PM	State Street Corp's Strategic Reduction in CareDx Inc Holdings (GuruFocus.com) -6.49%
Oct-16-24 08:17AM	CareDx Reports Strong Q3 2024 Revenue Growth (TipRanks)
Oct-15-24 06:00AM	CareDx Reports Preliminary Financial Results for Third Quarter 2024 (Business Wire) -15.84%
Oct-11-24 04:30PM	CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Oct-09-24 03:35PM	CareDx Inc (CDNA) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Positive Adjusted ... (GuruFocus.com) -12.42%
07:05AM	CareDx Appoints Jing Huang Chief Data and AI Officer (Business Wire)
Oct-08-24 04:05PM	CareDx to Host Investor Day on October 15, 2024 (Business Wire)
06:05AM	CareDx Announces Closure of DOJ Investigation with No Finding of Wrongdoing (Business Wire)
Sep-13-24 08:35PM	CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
08:33PM	CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Sep-12-24 07:01AM	CareDx Appoints Keith Kennedy Chief Operating Officer and Jessica Meng Chief Commercial Officer (Business Wire)
Aug-26-24 06:06AM	CareDx (CDNA) Surged Due to Positive Testing Volume Growth (Insider Monkey)
04:36AM	Here's Why Baron Discovery Fund Increased its Holdings in Veracyte (VCYT) (Insider Monkey)
Aug-16-24 02:10PM	CareDx Announces Transplant Community Secures Win Reaffirming Longstanding Medicare Coverage for AlloSure and AlloMap Testing (Business Wire) +16.40%
Aug-09-24 09:15AM	CareDx, Inc. (CDNA) Hit a 52 Week High, Can the Run Continue? (Zacks)
Aug-07-24 12:00PM	CareDx (CDNA) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
Aug-06-24 03:58PM	CareDx, Inc (CDNA): Among the Best Organ Transplant and Diagnosis Stocks to Buy According to Hedge Funds? (Insider Monkey) +5.57%
Jul-31-24 08:00PM	Compared to Estimates, CareDx (CDNA) Q2 Earnings: A Look at Key Metrics (Zacks) +6.56% +17.96%
06:05PM	CareDx (CDNA) Q2 Earnings and Revenues Beat Estimates (Zacks)
05:01PM	CareDx: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	CareDx Reports Second Quarter 2024 Results and Increases Revenue Guidance (Business Wire)
Jul-16-24 07:05AM	CareDx to Report Second Quarter 2024 Financial Results (Business Wire) +15.06%
Jun-03-24 07:05AM	Landmark Independent Publication in Nature Medicine Validates CareDx AlloView AI-Enabled Risk Prediction Model and Demonstrates AlloSure Kidney Detects Subclinical Rejection in Stable Patients (Business Wire)
May-30-24 07:05AM	AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant Congress (Business Wire)
May-29-24 08:05AM	CareDx Reiterates Position that it Does Not Infringe the 544 Patent, Injunction Motion is Irrelevant (Business Wire) -16.69%
07:05AM	CareDx to Participate in Upcoming Investor Conferences (Business Wire)
May-16-24 04:05PM	Landmark Study Shows CareDx's HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies (Business Wire)
May-14-24 07:17AM	--Raymond James Downgrades CareDx to Market Perform From Outperform (MT Newswires)
May-13-24 10:12AM	Stephens Adjusts Price Target on CareDx to $18 From $15, Maintains Overweight Rating (MT Newswires)
May-10-24 02:26PM	CareDx Shares Rise After Q1 Results Beat Estimates (MT Newswires) +34.09%
02:21PM	CareDx Reports Mixed Q1 2024 Results; Raises Annual Revenue Guidance (GuruFocus.com)
11:46AM	CareDx, Inc (NASDAQ:CDNA) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 07:00PM	CareDx (CDNA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) +8.64%
05:32PM	CareDx: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	CareDx Reports First Quarter 2024 Results (Business Wire)
May-07-24 09:15AM	CareDx (CDNA) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
May-03-24 04:10PM	CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-29-24 04:05PM	CareDx to Report First Quarter 2024 Financial Results (Business Wire) +8.47% -5.37%
Apr-19-24 04:05PM	CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-18-24 03:47AM	CareDx (CDNA) Moves 5.5% Higher: Will This Strength Last? (Zacks)
Apr-16-24 04:02PM	CareDx Appoints John W. Hanna as its New President and Chief Executive Officer (Business Wire) +5.48%
Apr-09-24 07:00AM	CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting (Business Wire)
Apr-01-24 08:40AM	How CareDx (CDNA) Stock Stands Out in a Strong Industry (Zacks)
Mar-11-24 04:10PM	CareDx Appoints Bryan Riggsbee to Its Board of Directors (Business Wire)
Feb-29-24 10:43AM	CareDx, Inc (NASDAQ:CDNA) Q4 2023 Earnings Call Transcript (Insider Monkey) +9.47%
06:59AM	Q4 2023 CareDx Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-28-24 07:00PM	CareDx (CDNA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:28PM	CareDx: Q4 Earnings Snapshot (Associated Press Finance)
04:57PM	CareDx Inc (CDNA) Surpasses Revenue Expectations Despite Net Loss Expansion in 2023 (GuruFocus.com)
04:05PM	CareDx Announces Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Feb-27-24 04:05PM	CareDx to Participate in the Raymond James & Associates 45th Annual Institutional Investors Conference (Business Wire) +6.39%
Feb-26-24 09:15AM	Unlocking Q4 Potential of CareDx (CDNA): Exploring Wall Street Estimates for Key Metrics (Zacks) +7.86%
Feb-21-24 04:05PM	CareDx to Report Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
07:00AM	CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings (Business Wire)
Jan-26-24 09:45PM	CareDx Issues Statement in Patent Infringement Case (Business Wire) -17.32% +9.53%
Jan-11-24 04:05PM	CareDx Adds to AlloSure Kidney and HeartCare Utility and Clinical Data at 2024 American Society of Transplant Surgeons Winter Symposium (Business Wire) -7.24%
Jan-09-24 07:00AM	CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2023 (Business Wire)
Dec-19-23 07:00AM	CareDx Joins Forces with the National Foundation for Transplants to Improve Post-Transplant Medication Adherence (Business Wire) +13.81%
Dec-08-23 09:55AM	How Much Upside is Left in CareDx (CDNA)? Wall Street Analysts Think 26.72% (Zacks)
Nov-22-23 09:55AM	Can CareDx (CDNA) Climb 29.79% to Reach the Level Wall Street Analysts Expect? (Zacks)

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jain Abhishek	Chief Financial Officer	Apr 07 '25	Sale	17.72	265	4,696	337,418	Apr 09 04:31 PM
Novack Jeffrey Adam	Secretary and General Counsel	Apr 07 '25	Sale	17.72	924	16,373	126,911	Apr 09 04:30 PM
Bickerstaff George	Director	Mar 10 '25	Sale	18.36	20,000	367,102	103,027	Mar 12 04:30 PM
GEORGE W BICKERSTAFF	Director	Mar 10 '25	Proposed Sale	18.36	20,000	367,102		Mar 10 05:03 PM
Novack Jeffrey Adam	Secretary and General Counsel	Feb 04 '25	Sale	23.30	3,512	81,829	104,677	Feb 05 04:30 PM
Jeffrey Adam Novack	Officer	Feb 04 '25	Proposed Sale	23.32	3,512	81,900		Feb 04 04:18 PM
Novack Jeffrey Adam	Secretary and General Counsel	Dec 04 '24	Sale	26.00	1,917	49,842	110,237	Dec 06 04:32 PM
Jeffrey Adam Novack	Officer	Dec 04 '24	Proposed Sale	24.96	1,917	47,848		Dec 04 04:42 PM
Maag Peter	Director	Nov 26 '24	Option Exercise	12.24	5,000	61,200	335,024	Dec 03 08:54 PM
Maag Peter	Director	Nov 26 '24	Sale	25.00	5,000	125,000	330,024	Dec 03 08:54 PM
Novack Jeffrey Adam	Secretary and General Counsel	Nov 18 '24	Sale	21.77	5,534	120,477	113,377	Dec 03 04:31 PM
Novack Jeffrey Adam	Secretary and General Counsel	Nov 25 '24	Sale	24.00	1,223	29,352	112,154	Dec 03 04:31 PM
PETER MAAG	Director	Nov 26 '24	Proposed Sale	24.11	5,000	120,550		Nov 26 04:25 PM
JEFFREY NOVACK	Officer	Nov 25 '24	Proposed Sale	23.13	1,223	28,288		Nov 25 04:45 PM
JEFFREY NOVACK	Officer	Nov 18 '24	Proposed Sale	21.17	5,534	117,155		Nov 18 05:11 PM
Bickerstaff George	Director	Nov 01 '24	Option Exercise	5.74	7,481	42,962	123,027	Nov 05 04:42 PM
Johnson Alexander L	See Remarks	Aug 20 '24	Option Exercise	23.48	39,466	926,662	324,449	Aug 22 05:15 PM
Johnson Alexander L	See Remarks	Aug 21 '24	Option Exercise	23.48	21,557	506,158	306,540	Aug 22 05:15 PM
Johnson Alexander L	See Remarks	Aug 20 '24	Sale	33.17	39,466	1,309,087	284,983	Aug 22 05:15 PM
Johnson Alexander L	See Remarks	Aug 21 '24	Sale	32.58	21,557	702,327	284,983	Aug 22 05:15 PM
Maag Peter	Director	Aug 20 '24	Option Exercise	7.96	26,708	212,596	365,576	Aug 22 04:43 PM
Maag Peter	Director	Aug 20 '24	Sale	33.04	35,552	1,174,493	330,024	Aug 22 04:43 PM
Johnson Alexander L	See Remarks	Aug 19 '24	Sale	33.55	34,231	1,148,335	284,983	Aug 21 04:38 PM
Johnson Alexander L	Officer	Aug 20 '24	Proposed Sale	33.00	61,023	2,013,759		Aug 20 06:25 PM
Johnson Alexander L	Officer	Aug 19 '24	Proposed Sale	33.55	34,231	1,148,355		Aug 20 06:21 PM
Maag Peter	Director	Aug 20 '24	Proposed Sale	33.51	35,552	1,191,478		Aug 20 05:13 PM
Bickerstaff George	Director	May 14 '24	Option Exercise	10.00	5,255	52,550	104,976	May 16 04:38 PM
Maag Peter	Director	Apr 29 '24	Option Exercise	5.27	13,281	69,991	327,264	May 01 04:38 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CDNA

Caredx Inc

Upgrade your FINVIZ experience